This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the First Trust NASDAQ Transportation ETF (FTXR)?
by Zacks Equity Research
Sector ETF report for FTXR
Should You Invest in the U.S. Global Jets ETF (JETS)?
by Zacks Equity Research
Sector ETF report for JETS
Sector ETFs to Gain the Most on COVID-19 Vaccine Rollout
by Sweta Killa
The United States has geared up for the largest-ever immunization with the rollout of the COVID-19 vaccine.
Sector ETFs to Win & Lose on Oil Price Rebound
by Sanghamitra Saha
This has been a tough year for the oil sector with prices tumbling in the first half of the year and gaining in the latter half of the year.
ETFs to Win & Lose From the Surge in Oil Price
by Sweta Killa
Oil price has been on a surge in recent months buoyed by solid development on the COVID-19 vaccine front.
Should You Invest in the U.S. Global Jets ETF (JETS)?
by Zacks Equity Research
Sector ETF report for JETS
5 Sector ETFs Still At Cheap Prices Amid Peak Market
by Sweta Killa
Though many sectors are hitting new highs amid the peak market, some funds are still down from a year-to-date look and are due to climb in the coming weeks.
5 ETFs at the Forefront of the Latest Market Rally
by Sweta Killa
Wall Street has hit a series of record highs with the four indices - the S&P 500, the Dow Jones, the Nasdaq Composite and the small-cap Russell 2000 - closed at new highs for the first time since January 2018 at the same time.
After a Historic November, What Awaits ETFs in December?
by Sweta Killa
Let's delve into some of the major events of December and learn how to tap the opportune moments with ETFs.
5 ETF Areas of November That Are Up At Least 25%
by Sanghamitra Saha
Back-to-back upbeat vaccine update, stimulus hopes and a divided government have boosted Wall Street in November.
ETF Sectors to Bet on Positive Vaccine News
by Sweta Jaiswal, FRM
The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.
ETFs to Win/Lose From Thanksgiving Amid COVID-19 Restrictions
by Sanghamitra Saha
Thanksgiving meal is cheaper this year. Spending on Thanksgiving celebrations will likely go up, which should benefit grocers and retailers. However, travels are likely to see a decline due to COVID-19.
6 ETFs to Consider as Thanksgiving Week Begins
by Sweta Jaiswal, FRM
Let's look at some ETFs that are expected to benefit from consumer shopping and celebrations as the Thanksgiving week begins.
Celebrate Thanksgiving Week With These ETFs
by Sweta Killa
Thanksgiving week is here and history shows that this holiday-shortened week is a bullish feast for stock investors.
Should You Invest in the U.S. Global Jets ETF (JETS)?
by Zacks Equity Research
Sector ETF report for JETS
ETF Strategies to Play as Vaccine Hopes Firm With Moderna Data
by Sanghamitra Saha
It???s been really a sweet November for the global economy and markets thanks to back-to-back release of upbeat coronavirus vaccine data from Moderna and Pfizer.
Leisure Stocks & ETFs Rally on Strong Vaccine Hopes
by Sanghamitra Saha
Hopes of a sooner-than-expected coronavirus vaccine launch led Wall Street to a record high on Nov 16 .
Biggest ETF Winners from Coronavirus Vaccine News
by Neena Mishra
Promising vaccine results from Pfizer sent economically sensitive stocks soaring
ETFs Riding the Latest Coronavirus Vaccine Optimism Wave
by Sweta Jaiswal, FRM
The coronavirus vaccine progress has brought back optimism for some ETFs, which were largely affected by the outbreak-led slowdown in economic activities.
Vaccine Hopes & Divided Government: Sector ETFs to Win
by Sanghamitra Saha
News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial has instilled more optimism in the markets.
5 ETFs Up Double Digits in a Day on Vaccine Optimism
by Sanghamitra Saha
Wall Street soared on Nov 9 on news that Pfizer (PFE) and BioNTech (BNTX) vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial.
Should You Invest in the First Trust NASDAQ Transportation ETF (FTXR)?
by Zacks Equity Research
Sector ETF report for FTXR
Should You Invest in the U.S. Global Jets ETF (JETS)?
by Zacks Equity Research
Sector ETF report for JETS
Top ETF Stories of the Volatile October
by Sanghamitra Saha
October 2020 saw some solid stock market gyrations due to election uncertainty and rising virus cases.
Should You Invest in the First Trust NASDAQ Transportation ETF (FTXR)?
by Zacks Equity Research
Sector ETF report for FTXR